...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: reply from Sarah

 

Sarah Zapotichny

5:01 PM (36 minutes ago)
 
 
 
 
 
 
 
 
 
 
 
"Hi xxxxxx - this is not a regulated market - it is OTC and does not reflect the actual value of shares."
Share
New Message
Please login to post a reply